Metraipolis › archive › dc_22c10b437ffe

An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation — Europe PMC PMID:39770487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39770487
DOI
10.3390/ph17121645
License (as archived)
solo-consultazione
Archived
2026-10-06T10:21:25.711Z
SHA-256 of the archived text
100a6f029061152edb136d59a715fb80750c463a8e1e08df68220903bc71544d
Stable URL of this page
https://metraipolis.com/documento/dc_22c10b437ffe

How to cite

An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation — Europe PMC PMID:39770487 — Europe PMC (en), https://europepmc.org/article/MED/39770487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22c10b437ffe (Metraipolis archive dc_22c10b437ffe, sha256 100a6f029061152edb136d59a715fb80750c463a8e1e08df68220903bc71544d)
BibTeX
@misc{dc22c10b437ffe,
  title = {An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation — Europe PMC PMID:39770487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39770487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22c10b437ffe; sha256 100a6f029061152edb136d59a715fb80750c463a8e1e08df68220903bc71544d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39770487. Agents can read the archived copy with the MCP tool read_document.